Abstract
All‐trans retinoic acid (ATRA) can down regulate the anti‐apoptotic protein Bcl‐2 and the cell cycle proteins cyclin D1 and cdk2 in estrogen receptor‐positive breast cancer cells. We show here that retinoids can also reduce expression of the inhibitor of apoptosis protein, survivin. Here we have compared the regulation of these proteins in MCF‐7 and ZR‐75 breast cancer cells by natural and synthetic retinoids selective for the RA receptors (RARs) α, β, and γ then correlated these with growth inhibition, induction of apoptosis and chemosensitization to Taxol. In both cell lines ATRA and 9‐cis RA induced the most profound decreases in cyclin D1 and cdk2 expression and also mediated the largest growth inhibition. The RARα agonist, Ro 40‐6055 also strongly downregulated these proteins although did not produce an equivalent decrease in S‐phase cells. Only ATRA induced RARβ expression. ATRA, 9‐cis RA and 4‐HPR initiated the highest level of apoptosis as determined by mitochondrial Bax translocation, while only ATRA and 9‐cis RA strongly reduced Bcl‐2 and survivin protein expression. Enumeration of dead cells over 96 h correlated well with downregulation of both survivin and Bcl‐2. Simultaneous retinoid‐mediated reduction of both these proteins also predicted optimal Taxol sensitization. 4‐HPR was much weaker than the natural retinoids with respect to Taxol sensitization, consistent with the proposed requirement for reduced Bcl‐2 in this synergy. Neither the extent of cell cycle protein regulation nor AP‐1 inhibition fully predicted the antiproliferative effect of the synthetic retinoids suggesting that growth inhibition requires regulation of a spectrum of RAR‐regulated gene products in addition even to pivotal cell cycle proteins. © 2003 Wiley‐Liss, Inc.